HKEY-AI-NAM-Bridge™ 1.0: HKeyBio Connects AI, NAMs and In Vivo Evidence
HKEY-AI-NAM-Bridge™ 1.0 connects AI predictions, new approach methodologies and in vivo evidence for more targeted preclinical study design BOSTON and SUZHOU, China, July 13, 2026 /PRNewswire/ -- HKeyBio has established HKEY-AI-NAM-Bridge™ 1.0, its...
Xellar Raises $50 Million Series A Financing to Build the Future of 3D Bio Intelligence
Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery BOSTON, June 30, 2026 /PRNewswire/ -- Xellar Biosystems today announced the closing of $50...
ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation
SHANGHAI, April 7, 2026 /PRNewswire/ -- ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreement with Daiichi Sankyo to leverage ATLATL's...
The Science of Longevity: Inside Prof. Mike Chan's Vision for Living Stronger, Smarter, and Longer
BANGKOK, Dec. 1, 2025 /PRNewswire/ -- Malaysia had a rare moment of reflection this year when former Prime Minister Tun Dr. Mahathir Mohamad turned 100. His milestone sparked public conversations about aging, vitality, and what it truly means to...